ReviewPrzeglad gastroenterologiczny2024

Resistance to death pathway induction as a potential targeted therapy in CRISPR/Cas-9 knock-out colorectal cancer cell lines.

Malgorzata Adamiec-Organisciok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.